HELUS THERAPEUTICS
Live / Allowed — Notice of allowance issued (as of 04 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Dec 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99524591
- Mark type
- Word mark
- Filed
- 02 Dec 2025
- Published for opposition
- 09 Jun 2026
- Attorney of record
- Kimberly Bullock Gatling
Goods and services
- Class 001 — Chemicals: Active chemical ingredients for use in the manufacture of pharmaceuticals for treating mental health disorders
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of neurological conditions and psychiatric conditions; Pharmaceutical preparations for the treatment of depression and anxiety
- Class 042 — Scientific and technological services: Pharmaceutical drug development services
Owner
- HELUS PHARMA CORP., TORONTO, CA
- Cybin Corp., Toronto, ON, CA
- Cybin Corp., Toronto, ON, CA
Prosecution history
- 26 Aug 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 04 Aug 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Jun 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jun 2026 — PUBLISHED FOR OPPOSITION
- 03 Jun 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 May 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 May 2026 — EXAMINER'S AMENDMENT ENTERED
- 08 May 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 08 May 2026 — EXAMINERS AMENDMENT E-MAILED
- 08 May 2026 — EXAMINERS AMENDMENT -WRITTEN
- 07 May 2026 — ASSIGNED TO EXAMINER
- 06 Apr 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Apr 2026 — NON-FINAL ACTION E-MAILED
- 06 Apr 2026 — NON-FINAL ACTION WRITTEN
- 05 Apr 2026 — ASSIGNED TO EXAMINER